ClassID:

94767

C07D277/50 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Nitrogen atoms Nitrogen atoms bound to hetero atoms

Sub-classes:
Recent Application in this class:
#1
20250206709
2025-06-26

METHOD FOR FORMING AMINOTHIAZOLE DERIVATIVES WITH SUPER-PARAMAGNETIC NANOPARTICLE CATALYST

#2
20250171410
2025-05-29

METHOD FOR FORMING A SCHIFF BASE WITH CATALYTIC SUPER-PARAMAGNETIC IRON OXIDE NANOPARTICLES

#3
20240300909
2024-09-12

2-aminothiazoles derivatives and method of preparation thereof using super-paramagnetic iron oxide nanoparticles (SPIONs)

#4
20220400678
2022-12-22

Oxime ether compound and application thereof

#5
20210299106
2021-09-30

Azophenols as ERG oncogene inhibitors

#6
20190336485
2019-11-07

Azophenols as ERG Oncogene Inhibitors

#7
20190292162
2019-09-26

Thiazole derivative and applications

#8
20190134008
2019-05-09

Applications of novel thiazole derivative in treating virus infection

#9
20180230106
2018-08-16

Substituted triazenes protected from degradation by carboxylation of N1

#10
20180169074
2018-06-21

Azophenols as ERG oncogene inhibitors

#11
20170306233
2017-10-26

Polymerizable compound and optically anisotropic body

#12
20170305895
2017-10-26

Substituted aminothiazoles for the treatment of tuberculosis

#13
20170260150
2017-09-14

Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display element, and organic EL display

#14
20170174644
2017-06-22

NAT10 modulators for treating or preventing laminopathies, aging and cancer

#15
20170114033
2017-04-27

Water-soluble triazabutadienes

#16
20160031874
2016-02-04

SUBSTITUTED AMINOTHIAZOLES FOR THE TREATMENT OF TUBERCULOSIS

#17
20150274872
2015-10-01

Polymerizable compound, polymerizable composition, polymer, and optical anisotropic body

#18
20140078577
2014-03-20

AZO compound and ink containing the compound

#19
20130338162
2013-12-19

COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS

#20
20130178505
2013-07-11

Compounds for the inhibition of cellular proliferation

#21
20130134409
2013-05-30

Photoelectric transducer and solid-state imaging apparatus

#22
20130078186
2013-03-28

Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates

#23
20110245262
2011-10-06

Compounds for treating proliferative disorders

#24
20100269269
2010-10-28

Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres

#25
20100151064
2010-06-17

Thiazolhydrazides for treatment of neurodegenerative diseases

#26
20100144805
2010-06-10

Regulation of protein synthesis

#27
20100087442
2010-04-08

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#28
20090298832
2009-12-03

Trisubstituted thiazole compounds, preparations methods, pharmaceutical compositions and medicals uses thereof

#29
20090203747
2009-08-13

Chemical compounds and the uses thereof as a medicine

#30
20090018141
2009-01-15

Kinase inhibitors, compositions thereof, and methods of use therewith

#31
20070213301
2007-09-13

Substituted Aminothiazole Derivatives With Anti-HCV Activity

#32
20070124872
2007-06-07

Method of coloring with capped diazotized compound and coupling component

#33
20060111303
2006-05-25

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

#34
20060069139
2006-03-30

Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof

#35
20050261294
2005-11-24

Substituted heteroaryl derivatives, compositions, and methods of use

#36
14918287
2016-10-04

Triazabutadienes as additives in adhesive systems